Enjoy complimentary customisation on priority with our Enterprise License!
The preeclampsia laboratory testing market size is forecast to increase by USD 855.3 million at a CAGR of 8.09% between 2023 and 2028. The market is witnessing significant growth due to several key trends and factors. One of the primary drivers is the market expansion in emerging economies, where the incidence of preeclampsia is increasing due to rising maternal obesity and diabetes. Another trend is the growing need for companion diagnostics, which help in early detection and personalized treatment of preeclampsia. However, challenges persist in the form of a lack of awareness and limited healthcare services in developing regions, which hinder the widespread adoption of laboratory testing for preeclampsia. Despite these challenges, the market is expected to grow at a steady pace, driven by advancements in diagnostic technologies and increasing government initiatives to improve maternal health.
Preeclampsia, a pregnancy complication characterized by high blood pressure and organ dysfunction, primarily affects pregnant women during the second half of their term. The global preeclampsia diagnostics market is witnessing significant growth due to the increasing prevalence of preeclampsia, high teenage pregnancy rates, and the need for early detection to ensure effective disease management. Infections, such as malaria, are major risk factors for preeclampsia. Laboratory tests play a crucial role in diagnosing preeclampsia by identifying high blood pressure, liver, and kidney dysfunction. Novel technologies, including point-of-care (POC) products, are gaining popularity due to their convenience and ability to provide quick results, enhancing patient satisfaction and treatment adherence.
The market is driven by the growing population, increasing health and safety concerns, and the demand for personalized medicinal products. The market is also witnessing significant innovation, with medical technologies being developed to improve the accuracy and reliability of preeclampsia diagnostics. Raw materials used in the production of laboratory tests are a critical factor influencing market growth. Lifestyle disorders, such as obesity and diabetes, are also contributing to the rising incidence of preeclampsia. Antenatal care centers are increasingly adopting advanced diagnostic tools to ensure early detection and effective management of preeclampsia, thereby reducing the risk of complications for both the mother and the baby.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The consumables segment is estimated to witness significant growth during the forecast period. Preeclampsia, a pregnancy complication characterized by high blood pressure and organ dysfunction, necessitates timely and accurate diagnosis for effective disease management. Laboratories play a crucial role in preeclampsia diagnostics, utilizing various tests to identify potential infections, such as malaria, and monitor biomarkers associated with preeclampsia. Consumables, including reagents, are essential components for these procedures, with the consumable segment experiencing growth due to their frequent usage and cost-effective nature. Labs and hospitals increasingly purchase consumables online, driving sales in this sector. Moreover, the rising awareness of preeclampsia, fueled by patient advocacy groups and health insurance policies, is leading to an increase in antenatal care visits and early detection of preeclampsia.
This trend is further driven by the availability of point-of-care (POC) products, which enable precise diagnosis and treatment adherence, especially in resource-limited settings. Novel technologies, such as personalized medicinal products and biomarker-based tests, are also gaining traction in the market, enhancing patient satisfaction and improving population health and safety. The diagnostic centers' demand for raw materials and high-quality consumables is expected to continue, as they strive to provide efficient and reliable services.
Get a glance at the market share of various segments Request Free Sample
The consumables segment accounted for USD 921.20 million in 2018 and showed a gradual increase during the forecast period.
Europe is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
Preeclampsia, a pregnancy complication characterized by hypertension and signs of damage to various organs, necessitates timely diagnosis and medical intervention. Disease pathogenesis involves the formation of new blood vessels with impaired function, leading to hypertension and potential organ damage. Diagnostic laboratories play a crucial role in identifying this condition through blood tests, which can detect protein levels in the urine and abnormalities in blood pressure readings. Medical intervention may include hospitalization, aspirin dose adjustments, and calcium supplements to manage symptoms and prevent complications. Blood tests are essential for monitoring disease progression and determining the most effective treatment plan.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Market expansion in emerging economies is the key driver of the market. The global market for preeclampsia diagnostics is experiencing significant growth due to several factors, particularly in emerging economies such as China, India, and Brazil. This expansion is driven by the rising incidence of health complications among pregnant women and fetuses, including high blood pressure, organ dysfunction in the kidneys and liver, and infections such as malaria and UTIs. Additionally, the growing number of high-risk pregnancies, including chromosomal abnormalities and multifetal pregnancies, is contributing to the demand for advanced preeclampsia laboratory testing. Furthermore, increasing awareness about healthcare devices and disease management, as well as patient satisfaction and treatment adherence, are key factors fueling market growth.
The development of personalized medicinal products and point-of-care (POC) products is also driving demand for preeclampsia laboratory testing. Government initiatives for the development of the healthcare sector, investments in the private healthcare sector, and the increasing awareness of preeclampsia through patient advocacy groups and health insurance policies are also contributing to market growth. The use of novel technologies, such as biomarkers and precision medicine, is expected to further boost the market. The population at risk for preeclampsia is increasing due to lifestyle disorders, medical technologies, and antenatal care. The demand for early detection and diagnosis of preeclampsia is, therefore, on the rise, leading to an increase in the consumption of laboratory tests and raw materials in diagnostic centers, hospitals, and clinics.
The growing need for companion diagnostics is the upcoming trend in the market. Preeclampsia, a pregnancy complication characterized by high blood pressure and organ dysfunction, primarily affects pregnant women. Early detection is crucial for effective disease management and improving patient outcomes. Companion diagnostics, specifically in-vitro point-of-care (POC) medical devices, play a significant role in preeclampsia diagnostics. These devices provide essential information for the safe and effective use of personalized medicinal products. Preeclampsia laboratory testing products, a subset of POC devices, are gaining popularity due to their ability to assist in prescribing decisions. The increasing awareness of preeclampsia, driven by patient advocacy groups and health insurance policies, fuels market growth. Novel technologies, such as biomarker-based diagnostics, offer precision and early detection, reducing preterm births and associated complications.
Hospitals, clinics, and diagnostic centers are major consumers of these products. Raw materials and consumables are essential components of preeclampsia laboratory testing, ensuring health and safety. Infections, such as malaria, can complicate preeclampsia diagnosis, necessitating advanced diagnostic technologies. Overall, the market is poised for growth, driven by population health and safety concerns, lifestyle disorders, and the need for personalized medicines.
Lack of awareness and limited healthcare services in developing regions is a key challenge affecting the market growth. Preeclampsia, a serious pregnancy complication characterized by high blood pressure and organ dysfunction, necessitates early and accurate diagnosis for effective disease management. In developing countries, where preeclampsia prevalence is high due to factors like teenage pregnancy rates and infections such as malaria, the lack of accessible and affordable diagnostic facilities poses a significant challenge. To address this, there is a pressing need to expand healthcare infrastructure, including preeclampsia diagnostics, in these regions. Moreover, companies in the market must adapt by offering POC products and personalized medicinal products at affordable prices. Additionally, promoting awareness of preeclampsia through patient advocacy groups, health insurance policies, and antenatal care centers can encourage early diagnosis and improve patient satisfaction and treatment adherence.
Novel technologies, such as biomarker-based tests for precision diagnosis, and collaborations with diagnostic centers, hospitals, and clinics, can further enhance the market's growth. The global market's expansion is crucial for ensuring health and safety, particularly in populations with increased risk factors, and for reducing preterm births.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company provides a range of laboratory testing services for the detection of preeclampsia, including the utilization of advanced technologies such as the i-STAT TOTAL beta-hCG CARTRIDGE.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The preeclampsia diagnostics market is experiencing significant growth due to increasing awareness of the disease, rising teenage pregnancy rates, and the need for early detection. Preeclampsia is a pregnancy complication characterized by high blood pressure and organ dysfunction, specifically affecting the kidneys and liver. Infections, such as malaria, can also contribute to the development of preeclampsia. Laboratory tests play a crucial role in the diagnosis and disease management of preeclampsia. POC products have gained popularity in recent years due to their convenience and ability to provide quick results. Consumables used in these tests, including raw materials for reagents and assays, are in high demand.
Novel technologies, such as personalized medicinal products and biomarker-based tests, are being developed to improve precision and treatment adherence. Patient satisfaction is a key consideration in the market, as pregnant women require regular antenatal care and frequent testing. Patient advocacy groups and health insurance policies are driving demand for preeclampsia diagnostics, particularly in hospitals, clinics, and diagnostic centers. The population at risk for preeclampsia includes those with lifestyle disorders and preterm births. Overall, the market for preeclampsia diagnostics is expected to grow as the importance of health and safety during pregnancy becomes increasingly recognized.
Market Scope |
|
Report Coverage |
Details |
Page number |
172 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.09% |
Market growth 2024-2028 |
USD 855.3 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
7.32 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
Europe at 35% |
Key countries |
US, Germany, China, UK, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, ACON Laboratories Inc., Avecon Healthcare Pvt. Ltd., Bio Rad Laboratories Inc., BioCheck Inc., bioMerieux SA, Biora Therapeutics Inc., Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., GestVision Inc., Lifeassay Diagnostics Pty Ltd., MedGyn Products Inc., Metabolomic Diagnostics, MOMM Diagnostics, Perkin Elmer Inc., Quidelortho Corp., Sera Prognostics Inc., Siemens AG, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Test
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.